Latest Options Exercise News

Imugene Limited has launched a $20 million equity raising comprising a $12 million placement and an $8 million Share Purchase Plan, alongside issuing options, convertible notes, and warrants to support its azer-cel clinical program.

EOS management, including CEO Dr Andreas Schwer and CFO Clive Cuthell, have exercised over 3.3 million share options, with the CEO set to sell a significant portion to fund personal commitments.

Vintage Energy launches a $2.1 million entitlement offer to fund critical oil prospect evaluations and install a permanent connection to the Odin gas field, aiming to cut operating costs and advance drilling plans.

European Resources Limited (ASX: ERE) has announced a $4.26 million renounceable entitlement offer to accelerate exploration and metallurgical work at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, providing shareholders with a strategic opportunity amid significant recent resource growth.

Percheron Therapeutics has announced a $2.2 million non-renounceable entitlement offer at a 20% discount, including free options, to fund the next phase of its lead oncology asset HMBD-002.

Findi Limited has extended the closing date of its offer to 19 March 2026 and updated details following a $25 million institutional placement. The company’s share capital structure and financial position have been revised, with key changes including director participation and lead manager incentives.

Excite Technology Services has secured $1.05 million through convertible notes, aiming to capitalise on its strongest operational cash flow quarter and accelerate growth.

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

ADX Energy has secured A$4.4 million through a well-supported placement to fund key exploration projects in Austria and Italy, alongside plans for a strategic dual listing on Oslo Børs’ Euronext Growth market.

Imugene Limited has launched a $20 million capital raising through a $12 million institutional placement and an $8 million Share Purchase Plan, alongside a convertible notes amendment to support its clinical development pipeline.

Evolution Energy Minerals has successfully closed an oversubscribed $4 million rights issue, supplemented by a $150,000 follow-on placement, bolstering funds for key exploration and development projects.

Vertex Minerals has renegotiated a $3 million loan and secured an additional $1.5 million facility to support underground development and gold production at its Reward Gold Mine, aiming to repay from positive cash flow in 2026.